Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Qb Flu

Drug Profile

Qb Flu

Alternative Names: gH1-Qbeta; H1N1 influenza VLP vaccine - A*STAR/Cytos; Influenza A H1N1 virus-like particle vaccine - A*STAR/Cytos; Influenza-A virus vaccine - Cytos; Qb-Flu; Qb-VLP vaccine; Recombinant flu vaccine - A*STAR/Cytos

Latest Information Update: 27 Feb 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Agency for Science, Technology and Research
  • Developer Agency for Science, Technology and Research; Cytos Biotechnology; Singapore Immunology Network
  • Class Influenza virus vaccines; Virus-like particle vaccines
  • Mechanism of Action B cell stimulants; Helper-inducer T-lymphocyte modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Influenza A virus H1N1 subtype

Most Recent Events

  • 13 May 2014 Qb Flu is available for licensing as of 05 May 2014. http://www.cytos.com
  • 05 May 2014 Suspended - Phase-I for Influenza-A virus H1N1 subtype in Singapore (Parenteral)
  • 29 Jan 2014 Immunogenicity data from a phase I trial in Influenza-A virus H1N1 subtype (prevention, in volunteers) released by Cytos Biotechnology and Agency for Science, Technology and Research
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top